Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations.

J Enzyme Inhib Med Chem · 2022 · PMC9154796 · PMID 35635148

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

The novel anticancer discovering or developing DNA intercalators is one of the extremely significant objectives in medicinal chemistry 27 .

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.